CZ
Charles Zhu LifeSci Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
CBIO
1
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $14.24 | $22 |
54%
upside
| Outperform |
18 Jun ‘25
2 months ago |
|
2
Tango Therapeutics
TNGX
$772M
| $6.94 | $8 |
15%
upside
| Buy |
7 Nov ‘24
10 months ago |
|
3
MacroGenics
MGNX
$126M
| $2 | $12 |
500%
upside
| Buy |
7 Nov ‘23
1 year ago |
|
4
Merus
MRUS
$5.1B
| $67.47 | $48 |
29%
downside
| Buy |
8 Aug ‘23
2 years ago |
|
5
Nuvalent
NUVL
$5.83B
| $80.89 | $56 |
31%
downside
| Buy |
24 Jul ‘23
2 years ago |
|
6
Protara Therapeutics
TARA
$122M
| $3.15 | $22 |
598%
upside
| Buy |
10 Jul ‘23
2 years ago |
|
7
Cogent Biosciences
COGT
$1.82B
| $13.05 | $26 |
99%
upside
| Buy |
13 Jun ‘23
2 years ago |
|
8
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $32 |
18%
upside
| Buy |
8 Mar ‘23
2 years ago |
|
9
Zymeworks
ZYME
$1.14B
| $15.05 | $14 |
7%
downside
| Buy |
5 May ‘22
3 years ago |
|